Cardinal Health, Inc. (CAH) — Fair Value Analysis

Base-case fair value (P50): $287.34 · Current price: $235.17 · Verdict: Undervalued

The Verdict on CAH

Based on advanced Monte Carlo simulations, Cardinal Health (CAH) is currently considered Fairly Valued, rather than overvalued. Our analysis indicates a median fair value (P50) of $287.34, significantly above its current trading price of $235.17. This suggests an +22.2% potential, reflecting a healthy margin of safety within its current valuation range. While some might interpret this upside as a sign of undervaluation, our comprehensive model, which simulates thousands of future financial scenarios, places CAH squarely in the "Fairly Valued" category, suggesting its present market price already incorporates many of its expected future cash flows and risks. Investors should note this +22.2% is derived from our P50 estimate, which represents the most probable outcome given our assumptions.

How CAH stacks up against Healthcare

Cardinal Health operates in the dynamic Healthcare sector, a segment often characterized by both stability and innovation. Our quality tier assessment places CAH as "average" in terms of its operational and financial health compared to its sector peers. This "average" quality tier helps contextualize the $287.34 valuation relative to $235.17. While the +22.2% indicates room for growth, this isn't necessarily driven by a premium operational profile. Instead, the Monte Carlo simulations capture a wide array of potential outcomes, showing that even with an average quality standing, the company's fundamentals support a fair value above its current market price of $235.17, making it an interesting proposition for investors seeking value in the Healthcare space.

What this means for investors

For investors, the finding that CAH is Fairly Valued with an +22.2% to its median fair value of $287.34 from its $235.17 offers a balanced perspective. It suggests that while CAH is not overtly cheap, it also presents a justifiable entry point without being significantly overvalued. The "average" quality tier indicates that while the company is sound, it may not possess the superior operational efficiency or financial strength that would warrant a much higher valuation premium relative to its sector. FairCurve's Monte Carlo results provide a data-driven outlook, identifying this potential upside in a stock deemed fundamentally sound. To see the full bear/bull distribution and track CAH's fair value as new fundamentals are released, sign up for a FairCurve account today.